Roche

Showing 15 posts of 710 posts found.

Roche building

Roche snaps up Tensha Therapeutics for up to $535m

January 12, 2016
Manufacturing and Production, Research and Development Roche, Tensha Therapeutics

Roche has acquired Tensha Therapeutics, a privately-held company based in Cambridge, Massachusetts for up to $535 million.The deal that gives …

Roche building

Roche presents new data for advanced bladder cancer immunotherapy

January 8, 2016
Medical Communications, Research and Development Roche, atezolizumab, bladder cancer

Roche has announced updated results from a pivotal Phase II study, showing its investigational cancer immunotherapy atezolizumab extended median progression …

NIHR logo

Roche teams with DH for drug repurposing trial

January 6, 2016
Research and Development DH, NIHR, Off Patent Drugs Bill, Off-Patent Drugs Bill, RoActemra, Roche, drug repurposing, tocilizumab

Roche and the UK Department of Health have launched a trial, to explore whether one of the company’s treatments for …

Kadcyla

NICE says no to NHS funding for Kadcyla

December 16, 2015
Research and Development, Sales and Marketing Breast Cancer Now, Kadcyla, NHS, NICE, Roche, advanced breast cancer, breast cancer

NICE has turned down Roche’s application for NHS funding for Kadcyla as a treatment for a type of advanced breast …

Chest x ray

Roche lung cancer drug Alecensa gets rapid US approval

December 14, 2015
Sales and Marketing Alecensa, FDA, Genentech, Roche, accelerated approval, alectinib, lung cancer, non-small cell lung cancer

The US health watchdog has approved Alecensa, a drug for people with certain types of non-small cell lung cancer manufactured …

roche_scientists

Which are pharma’s most innovative companies?

December 11, 2015
Medical Communications, Research and Development GSK, Roche, research and development

It has been a record-breaking year for the pharmaceutical industry in terms of deals, but what about the underlying innovation …

roche_claudia

New member appointed to Roche board of directors

December 9, 2015
Business Services Roche

The Roche board of directors has proposed Dr Claudia Süssmuth Dyckerhoff, currently senior partner at McKinsey & Company, for election …

Red blood cells

ASH 2015 roundup: Amgen, MorphoSys, Novartis and Roche present new trial data

December 8, 2015
Research and Development Amgen, Cancer, Novartis, Roche, ash, morphosys, oncology

Amgen Amgen presented data from three Phase II trials evaluating Blincyto (blinatumomab) in acute lymphoblastic leukemia (ALL)- a rare and …

NICE rejects Roche’s Kadcyla for NHS; price still too high

November 17, 2015
Manufacturing and Production, Sales and Marketing Cancer Drugs Fund, Kadcyla, NHS England, NICE, Roche

NICE has published final draft guidance on Roche’s Kadcyla as a breast cancer treatment, deciding that the drug’s price remains …

Roche building

Roche manufacturing restructure means EU, US jobs cuts

November 13, 2015
Manufacturing and Production, Medical Communications Roche, job cuts, job losses, manufacturing, production, redundancies, restructure

Roche has announced plans to restructure its manufacturing network for small molecules, in a move that will see it mothball …

Proteus Digital and Otuska's 'digital pill'

The ‘Pharmasaurus’ aims to evolve into a leader in the digital age

November 12, 2015
Medical Communications, Research and Development Bayer, Roche, digital health, pharma

Pharma’s new-found willingness to embrace all aspects of the digital age, and use it both to its advantage and that …

roche

FDA approves Roche skin cancer combination

November 11, 2015
Research and Development, Sales and Marketing Cotellic, FDA, Genentech, Roche, Zelboraf, cobimetinib, melanoma, skin cancer, vemurafenib

The FDA has approved the skin cancer drug Cotellic for certain forms of melanoma in combination with another Roche cancer …

Kadcyla

Roche under pressure to drop price of Kadcyla

October 27, 2015
Manufacturing and Production Cancer Drugs Fund, Kadcyla, Roche, breast cancer

The UK’s largest breast cancer charity has called for drug manufacturer Roche to drop the price of Kadcyla before it …

Severin Schwan

Roche buoyed by 6% sales growth

October 22, 2015
Sales and Marketing Roche, financial results

Roche has reported strong sales growth for the first nine months of 2015 and revised its sales outlook to reflect …

Genentech logo

Positive late-stage results for Genentech’s ocrelizumab in different forms of MS

October 8, 2015
Research and Development ECTRIMS, Genentech, MS, Roche, multiple sclerosis, ocrelizumab

Roche’s biotech arm Genentech has presented ‘transformative’ data at an international multiple sclerosis conference on its investigational drug ocrelizumab. Ocrelizumab …

The Gateway to Local Adoption Series

Latest content